Brain cell signaling abnormalities are detected in blood in a murine model of Fragile X syndrome and corrected by Sigma‐1 receptor agonist Blarcamesine

Daniel Klamer, Nell Rebowe, Jeffrey Sprouse, Christopher U. Missling, and Walter E. Kaufmann are employees or consultants of Anavex Life Sciences Corporation. The data that support the findings of this study are available from the corresponding author upon reasonable request.